Quality statement 5: Statins for primary prevention

Quality statement

Adults choosing statin therapy for the primary prevention of cardiovascular disease (CVD) are offered atorvastatin 20 mg.

Rationale

High‑intensity statins are the most clinically effective treatment option for the primary prevention of CVD – that is, reducing the risk of first CVD events. After a discussion of the risks and benefits of starting statin therapy with a healthcare professional, a person may choose statin therapy as an appropriate treatment to reduce their risk of CVD. When a person decides to have statin therapy, a statin of high intensity and low cost should be offered. Atorvastatin 20 mg is recommended as the preferred initial high‑intensity statin to use because it is clinically and cost effective for the primary prevention of CVD.

Quality measures

Structure

Evidence of local arrangements to ensure that adults who choose statin therapy for primary prevention are offered atorvastatin 20 mg.

Data source: Local data collection.

Process

Proportion of adults choosing statin therapy for primary prevention of CVD who are prescribed atorvastatin 20 mg.

Numerator – the number in the denominator prescribed atorvastatin 20 mg.

Denominator – the number of adults choosing statin therapy for primary prevention of CVD.

Data source: Local data collection.

What the quality statement means for service providers, healthcare professionals, and commissioners

Service providers (primary care) ensure that adults choosing statin therapy for primary prevention of CVD are offered atorvastatin 20 mg.

Healthcare professionals offer atorvastatin 20 mg to adults choosing statin therapy for primary prevention of CVD.

Commissioners (NHS England area teams and clinical commissioning groups) ensure that adults who choose statin therapy for primary prevention of CVD are offered atorvastatin 20 mg. Commissioners may do this by seeking evidence of practice through clinical audits.

What the quality statement means for patients, service users and carers

Adults at risk of CVD who choose to have a statin to reduce their chances of CVD are offered one called atorvastatin. This may help to reduce their chances of having a heart attack or stroke in the future.

Source guidance